Literature DB >> 11987983

Absence of memory B cells in patients with common variable immunodeficiency.

Kazunaga Agematsu1, Takeshi Futatani, Sho Hokibara, Norimoto Kobayashi, Masaya Takamoto, Satoshi Tsukada, Harumi Suzuki, Shigeo Koyasu, Toshio Miyawaki, Kazuo Sugane, Atsushi Komiyama, Hans D Ochs.   

Abstract

The molecular basis of common variable immunodeficiency (CVID) is unknown. To assess humoral immunity in CVID, we selected 24 patients with early or late onset of disease. X-linked agammaglobulinemia (XLA), X-linked hyper-IgM syndrome (XHIM), and non-XHIM were excluded based on clinical phenotype, assessment of the immune response, presence of Bruton's tyrosine kinase (Btk) in monocytes or platelets, and normal expression of CD40 ligand by activated T cells. The number of circulating B cells was within the normal range or reduced. IgD(-) CD27(+) memory B cells were markedly reduced or absent in all 24 patients and IgD(+) CD27(+) B cells were diminished in 8 patients. Circulating B cells from all 6 patients examined, including CVID patients with IgD(+) CD27(+) cells, failed to undergo somatic hypermutation in immunoglobulin-variable (V)-region genes, similar to cord blood B cells. B cells from CVID patients produced IgM and IgG, but not IgA upon the engagement of Ig receptor and CD40 in the presence of IL-2 and IL-10. B cells from all but 5 patients secreted IgE when stimulated by CD40 crosslinking in the presence of IL-4. The observation of defective memory B cells with abnormal cell marker expression and function demonstrates that naive CVID B cells including those expressing IgD(+) CD27(+), in analogy to cord blood and hyper-IgM syndrome B cells, may be responsible for their failure to differentiate into plasma cells and to produce high-affinity antibodies of different isotypes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11987983     DOI: 10.1006/clim.2001.5197

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  37 in total

1.  Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene.

Authors:  N Martinez-Pomar; S Raga; J Ferrer; J Pons; I Munoz-Saa; M-R Julia; J de Gracia; N Matamoros
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 2.  Therapeutic strategies in common variable immunodeficiency.

Authors:  W A Carrock Sewell; Matthew Buckland; Stephen R A Jolles
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 3.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

4.  IgH sequences in common variable immune deficiency reveal altered B cell development and selection.

Authors:  Krishna M Roskin; Noa Simchoni; Yi Liu; Ji-Yeun Lee; Katie Seo; Ramona A Hoh; Tho Pham; Joon H Park; David Furman; Cornelia L Dekker; Mark M Davis; Judith A James; Kari C Nadeau; Charlotte Cunningham-Rundles; Scott D Boyd
Journal:  Sci Transl Med       Date:  2015-08-26       Impact factor: 17.956

Review 5.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

6.  T and B lymphocyte subpopulations and activation/differentiation markers in patients with selective IgA deficiency.

Authors:  J Litzman; M Vlková; Z Pikulová; D Stikarovská; J Lokaj
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

7.  Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients.

Authors:  M Vlková; V Thon; M Sárfyová; L Bláha; A Svobodník; J Lokaj; J Litzman
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

8.  Thymic and bone marrow output in patients with common variable immunodeficiency.

Authors:  Federico Serana; Paolo Airò; Marco Chiarini; Cinzia Zanotti; Mirko Scarsi; Micol Frassi; Vassilios Lougaris; Alessandro Plebani; Luigi Caimi; Luisa Imberti
Journal:  J Clin Immunol       Date:  2011-04-14       Impact factor: 8.317

9.  Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.

Authors:  Li Zhang; Lin Radigan; Ulrich Salzer; Timothy W Behrens; Bodo Grimbacher; George Diaz; James Bussel; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2007-11       Impact factor: 10.793

10.  Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID).

Authors:  Karina I Carvalho; Karina M Melo; Fernanda R Bruno; Jennifer E Snyder-Cappione; Douglas F Nixon; Beatriz T Costa-Carvalho; Esper G Kallas
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.